Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions

Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions

Abstract Ticagrelor-based dual antiplatelet therapy (DAPT) provides potent antiplatelet inhibition but may increase the bleeding risk in Asian populations. We investigated the influence of early ticagrelor dose reduction (120 mg) on clinical outcomes in Korean patients undergoing percutaneous corona...

Full description

Bibliographic Details
Main Authors: Yonggu Lee, Jeong-Hun Shin, Suk Min Seo, Ik Jun Choi, Jong-Young Lee, Jun-Won Lee, Mahn-Won Park, Tae Soo Kang, Woong Gil Choi, Ki-Hyun Jeon, Hong-Seok Lim, Hyung Joon Joo, Sang Jae Rhee, Jae-Bin Seo, Myung Soo Park, Sang-Ho Park, Young-Hyo Lim
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-42655-4

Internet

https://doi.org/10.1038/s41598-023-42655-4

Similar Items